The bill establishes the Minnesota Parkinson's Research Trust Fund, aimed at supporting innovative research on Parkinson's disease and providing assistance to caregivers. It outlines the purpose of the fund, which includes improving health outcomes for residents, attracting scientific researchers, and fostering collaboration among educational institutions and research entities. The fund will be managed by the commissioner of health, who is authorized to award grants for various research initiatives and will oversee the administration through a newly formed Neurodegenerative Disease Advisory Council. This council will consist of representatives from research institutions, advocacy organizations, caregiver support groups, and the medical community.

Additionally, the bill appropriates $25 million from the general fund for fiscal year 2027 to implement the trust fund's objectives. Of this amount, $20 million is designated for competitive grants to research institutions focused on innovative therapies, $3 million is allocated for caregiver support programs, and $2 million is set aside for the establishment of the advisory council. The bill also mandates annual reporting requirements for grant recipients and the commissioner, ensuring transparency and accountability in the use of funds. The effective date for the trust fund is set for October 1, 2026, while the appropriation section will take effect on July 1, 2026.